PerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging

DOORwaY-90 Study for SIR-Spheres® Therapy as 1st-line Treatment for Hepatocellular Carcinoma Enrolls First Patient

The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres. It is being led by co-principal investigators Cheenu Kappadath, PhD and Dr. Armeen Mahvash.

Global Surgical Lasers Market to Reach $10.1 Billion by 2027

1 Billion by 2027, growing at a CAGR of 9.7% over the analysis period 2020-2027. Solid-State Laser Systems, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$3.9 Billion by the end of the analysis period.

Carestream Health Advances X-ray Image Quality with Smart Noise Cancellation

SNC has received FDA 510(k) Clearance and is available as an optional feature with Carestream’s ImageView Software powered by Eclipse—the intelligent image-processing engine behind the company’s innovative imaging software—on DRX-Evolution and DRX-Evolution Plus systems.

 

“The sale of Medical Imaging supports our strategy of redirecting our investments towards accelerating growth in key markets,” said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation (Nasdaq: VREX).

PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that serve as components for industrial, medical and dental X-ray imaging systems, on December 22, 2016.

“The sale of Medical Imaging supports our strategy of redirecting our investments towards accelerating growth in key markets,” said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles